Aspira Women's Health Faces Delisting Concerns

Ticker: AWHL · Form: 8-K · Filed: 2025-04-16T00:00:00.000Z

Sentiment: bearish

Topics: delisting, listing-standards, 8-k

TL;DR

Aspira Women's Health might get delisted, filing an 8-K about listing rule issues.

AI Summary

Aspira Women's Health Inc. filed an 8-K on April 16, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing also includes financial statements and exhibits. The company's principal executive offices are located at 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.

Why It Matters

This filing indicates potential issues with Aspira Women's Health Inc.'s compliance with stock exchange listing requirements, which could lead to the delisting of its shares.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can severely impact a company's stock.

Key Players & Entities

Aspira Women's Health Inc. (company) — Registrant
April 15, 2025 (date) — Earliest event reported
April 16, 2025 (date) — Date of report
12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738 (address) — Principal executive offices
VERMILLION, INC. (company) — Former company name
CIPHERGEN BIOSYSTEMS INC (company) — Former company name
ABIOTIC SYSTEMS (company) — Former company name

FAQ

What specific listing rule or standard has Aspira Women's Health Inc. failed to satisfy?

The filing does not specify the exact listing rule or standard that Aspira Women's Health Inc. has failed to satisfy, only that a notice has been issued.

What is the date of the earliest event reported in this 8-K filing?

The earliest event reported is dated April 15, 2025.

What is the primary purpose of this 8-K filing?

The primary purpose is to report a notice of delisting or failure to satisfy a continued listing rule or standard, and to include financial statements and exhibits.

Where are Aspira Women's Health Inc.'s principal executive offices located?

The principal executive offices are located at 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.

Has Aspira Women's Health Inc. had previous name changes?

Yes, the company was formerly known as VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC, and ABIOTIC SYSTEMS.

From the Filing

0001641172-25-005086.txt : 20250416 0001641172-25-005086.hdr.sgml : 20250416 20250416170730 ACCESSION NUMBER: 0001641172-25-005086 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250415 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250416 DATE AS OF CHANGE: 20250416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 25843500 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 8-K 1 form8-k.htm false 0000926617 0000926617 2025-04-15 2025-04-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       Form 8-K       CURRENT REPORT   Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): April 15, 2025       Aspira Women’s Health Inc. (Exact name of registrant as specified in its charter)       Delaware   001-34810   33-0595156 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)         12117 Bee Caves Road , Building III , Suite 100 , Austin , Texas   78738 (Address of principal executive offices)   (Zip Code)   Registrant’s telephone number, including area code: (512) 519-0400       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.001 per share   AWH   Nasdaq Capital Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing .   On April 15, 2025, Aspira Women’s Health Inc.